Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biocryst Pharmaceuticals Inc (BCRX)  
$4.45 0.03 (0.67%) as of 4:30 Fri 5/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 189,490,000
Market Cap: 843.23(M)
Last Volume: 2,734,155 Avg Vol: 4,454,926
52 Week Range: $4.13 - $8.81
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  455
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO™ (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 16,866 495,199
Total Sell Value $0 $0 $135,363 $5,999,241
Total People Sold 0 0 2 9
Total Sell Transactions 0 0 2 14
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 77
  Page 2 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Abercrombie George B Director   •       •      –    2021-05-24 4 OE $2.63 $17,534 D/D 6,667 9,667     -
   Barnes Alane P Chief Legal Officer   •       •      –    2021-05-12 4 OE $4.73 $169,580 D/D 35,852 146,127     -
   Barnes Alane P Chief Legal Officer   •       •      –    2021-05-11 4 S $12.04 $1,237,471 D/D (102,780) 110,275 -24%     
   Barnes Alane P Chief Legal Officer   •       •      –    2021-05-11 4 OE $1.42 $425,442 D/D 102,780 213,055     -
   Abercrombie George B Director   •       •      –    2021-05-10 4 S $12.70 $88,900 D/D (7,000) 3,000 -32%     
   Thackray Helen M. Chief R&D Officer   •       •      –    2021-03-31 4 A $0.00 $0 D/D 100,000 100,000     -
   Jones Michael L Exec. Director, Finance - PAO   •       •      –    2021-03-18 4 OE $3.51 $15,795 D/D 4,500 5,348     -
   Ingram Robert Alexander Director   •       •      –    2021-02-26 4 A $10.78 $18,746 D/D 1,739 75,013     -
   Aselage Steve Director   •       •      –    2021-02-26 4 A $10.78 $9,993 D/D 927 31,496     -
   Hutson Nancy J Director   •       •      –    2021-02-26 4 A $10.78 $4,991 D/D 463 64,756     -
   Heggie Theresa Director   •       •      –    2021-02-26 4 A $10.78 $4,991 D/D 463 13,849     -
   Sheridan William P Senior VP - CMO   •       •      –    2021-02-22 4 AS $11.57 $477,263 D/D (41,250) 11,475 45%     
   Sheridan William P Senior VP - CMO   •       •      –    2021-02-22 4 OE $4.15 $171,188 D/D 41,250 52,725     -
   Babu Yarlagadda S Senior VP - Drug Discovery   •       •      –    2021-02-19 4 D $11.53 $258,629 D/D (22,431) 183,156     -
   Babu Yarlagadda S Senior VP - Drug Discovery   •       •      –    2021-02-19 4 OE $4.15 $207,500 D/D 50,000 205,587     -
   Stonehouse Jon P President & CEO   •       •      –    2020-12-15 4 AS $8.32 $1,117,193 D/D (134,278) 784,086 48%     
   Stonehouse Jon P President & CEO   •       •      –    2020-12-15 4 OE $4.15 $557,254 D/D 134,278 918,364     -
   Barnes Alane P Senior VP, Chief Legal Officer   •       •      –    2020-12-11 4 AS $7.96 $109,378 D/D (13,741) 108,061 49%     
   Barnes Alane P Senior VP, Chief Legal Officer   •       •      –    2020-12-11 4 OE $4.15 $57,025 D/D 13,741 121,802     -
   Barnes Alane P Senior VP, Chief Legal Officer   •       •      –    2020-12-04 4 AS $6.23 $85,606 D/D (13,741) 108,061 84%     
   Barnes Alane P Senior VP, Chief Legal Officer   •       •      –    2020-12-04 4 OE $4.15 $57,025 D/D 13,741 121,802     -
   Hutson Nancy J Director   •       •      –    2020-11-30 4 A $5.11 $4,998 D/D 978 64,293     -
   Ingram Robert Alexander Director   •       •      –    2020-11-30 4 A $5.11 $18,749 D/D 3,669 73,274     -
   Heggie Theresa Director   •       •      –    2020-11-30 4 A $5.11 $4,998 D/D 978 13,386     -
   Aselage Steve Director   •       •      –    2020-11-30 4 A $5.11 $9,995 D/D 1,956 30,569     -
  77 Records found
  1  2  3  4   
  Page 2 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us